TrialThe Journal of allergy and clinical immunology2015

Skin test evaluation of a novel peptide carrier-based vaccine, BM32, in grass pollen-allergic patients.

Verena Niederberger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.